Nurx Secures $36M in Series B

Nurx

San Francisco, CA
800-321-NURX
http://app.nurx.co/

Key contact

Name Title
Hans Gangeskar Co-Founder
SAN FRANCISCO, CA, Nurx has raised $36 million in a Series B funding round led by Kleiner Perkins.
According to MobiHealthNews, Nurx has raised $36 million in a Series B funding round led by Kleiner Perkins Caufield & Byers, with participation from Union Square Ventures, Y Combinator, and Lowercase Capital.

Nurx is a telehealth company committed to being a global industry leader in a market projected to surpass $36 billion by 2020. Founded by a Hans Gangeskar and Dr. Edvard Engesaeth, MD, Nurx makes birth control and Truvada for PrEP more accessible through telemedicine. Users are able to receive prescriptions with online doctors and have their medication delivered right to their door through the app.

Funding Events

Date Amount Type Investors Lead investor
01/11/2016 $5,300,000 Series A Lowercase Capital, SV Angel, Union Square Ventures, Y Combinator
14/07/2018 $36,000,000 Series B Kleiner Perkins Caufield and Byers, Lowercase Capital, Union Square Ventures, Y Combinator Kleiner Perkins Caufield and Byers